Larger than Life Science: Faster Forward When Vaccine Development Goes Virtual

Description

While scientists race to understand Covid-19, the research industry is in the midst of its own “Industrial Revolution”. Virtual trials are now a reality—and we must learn to adapt. Virtual trials are the aggregation of safety and efficacy data from participants. These cutting-edge trials take full advantage of technologies, apps, monitoring devices, and social platforms to conduct various aspects of the clinical trial. All from the comfort and safety of the patients’ home. This includes telemedicine utilization for recruitment, informed consent, patient counseling, remote contacts as well as measurements of clinical endpoints through deployment of wearables, ePRO and other tools/devices. In this session with experts from Celerion, you will learn:
 

• How to achieve faster proof of concept for vaccine development using a trusted early development partner to accelerate the process from healthy normal evaluation to patient efficacy
• How rapid, close scientific consultation drives appropriate study design, endpoints, and clinical operational expertise
• How dedicated bioanalytical and clinical pharmacology sites work in tandem to sharing results in real-time for adaptive data-driven results